Difference between revisions of "2016-01-13 PLA WGM Agenda"
Jump to navigation
Jump to search
Anne wizauer (talk | contribs) |
Anne wizauer (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 42: | Line 42: | ||
| || Woody Beeler | | || Woody Beeler | ||
|- | |- | ||
− | | ||Lorraine Constable | + | |x ||Lorraine Constable |
|- | |- | ||
| ||Bo Dagnall | | ||Bo Dagnall | ||
Line 58: | Line 58: | ||
| || Lynn Laakso | | || Lynn Laakso | ||
|- | |- | ||
− | | || Mary Kay McDaniel | + | | x|| Mary Kay McDaniel |
|- | |- | ||
| || Brian Pech | | || Brian Pech | ||
Line 86: | Line 86: | ||
*Agenda review | *Agenda review | ||
*Discussion Topics: | *Discussion Topics: | ||
+ | **V2 status | ||
+ | **Discuss V2 methodology – InM coordinating with CGIT | ||
*notional division of products into product families and lines, to provide examples for peer review. | *notional division of products into product families and lines, to provide examples for peer review. | ||
Line 96: | Line 98: | ||
===Minutes=== | ===Minutes=== | ||
+ | *V2 publishing | ||
+ | **Reach out to publishing for update to M&C | ||
+ | *Discuss V2 methodology – InM coordinating with CGIT and Vocabulary | ||
+ | **Reach out to InM – invite all co-chairs to call to discuss next steps for integration. | ||
+ | **SGB will take over governance for 2.x | ||
+ | **Does V2 publishing group stop reporting to SD and report directly to SGB? Can publishing move in pieces? | ||
+ | *ACTIONS: | ||
+ | **1) outreach to InM; formal request/notification to SGB to tell them that they’re providing governance to 2.x (Mary Kay will send email to chairs) | ||
+ | **2) Clarify who approves standing up a product family management group and methodology group – looks as though it would be approved by SGB and then by TSC (Check with Tony) | ||
+ | **3) Obtain an inventory of the product | ||
+ | **4) Craft form for product family creation | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
{|border="1" cellpadding="2" cellspacing="0" | {|border="1" cellpadding="2" cellspacing="0" |
Latest revision as of 18:41, 24 February 2016
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Plaza International Ballroom I |
Date: 2016-01-13 Time: 3:30 PM Eastern | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Woody Beeler | |||
x | Lorraine Constable | ||
Bo Dagnall | |||
Jean Duteau, | |||
Rick Haddorff | |||
Tony Julian | |||
Paul Knapp | |||
x | Austin Kreisler, | ||
Lynn Laakso | |||
x | Mary Kay McDaniel | ||
Brian Pech | |||
John Quinn | |||
John Roberts | |||
Andy Stechishin | |||
no quorum definition |
Agenda
- Agenda review
- Discussion Topics:
- V2 status
- Discuss V2 methodology – InM coordinating with CGIT
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
- V2 publishing
- Reach out to publishing for update to M&C
- Discuss V2 methodology – InM coordinating with CGIT and Vocabulary
- Reach out to InM – invite all co-chairs to call to discuss next steps for integration.
- SGB will take over governance for 2.x
- Does V2 publishing group stop reporting to SD and report directly to SGB? Can publishing move in pieces?
- ACTIONS:
- 1) outreach to InM; formal request/notification to SGB to tell them that they’re providing governance to 2.x (Mary Kay will send email to chairs)
- 2) Clarify who approves standing up a product family management group and methodology group – looks as though it would be approved by SGB and then by TSC (Check with Tony)
- 3) Obtain an inventory of the product
- 4) Craft form for product family creation
Meeting Outcomes
Actions
|
© 2016 Health Level Seven® International. All rights reserved